BKHAR Black Hawk Acquisition Corp

Nasdaq Biological Products, (No Diagnostic Substances) CIK: 0002000775
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

Black Hawk Acquisition Corp exhibits severe financial distress with negative stockholders' equity of -$3.8M, indicating the company is technically insolvent. The combination of negative operating cash flow (-$650.3K), zero cash reserves, deteriorating revenue (-9.1% YoY), and extremely weak liquidity ratios (0.03x) creates an unsustainable financial position. The apparent profitability in net income is misleading given negative operating income and likely driven by non-recurring gains rather than core business operations.

Strengths

  • + Net margin appears positive at 58.9%, though driven by non-operating gains rather than core operations
  • + Long-term debt is minimal at $4.5K
  • + Company maintains some asset base of $23.9M despite negative equity

Risks

  • ! Negative stockholders' equity of -$3.8M indicates technical insolvency and structural balance sheet failure
  • ! Critically low liquidity with current ratio of 0.03x and zero cash equivalents creates immediate solvency concerns
  • ! Negative operating income of -$915.5K and negative operating cash flow of -$650.3K demonstrate the core business is not viable
  • ! Revenue declining 9.1% YoY with deteriorating operations suggests business contraction
  • ! No insider activity in past 90 days may indicate lack of confidence from management

Key Metrics to Watch

Financial Metrics

Revenue
2.3M
Net Income
1.3M
EPS (Diluted)
$0.00
Free Cash Flow
-650.3K
Total Assets
23.9M
Cash
0.0

Profitability Ratios

Gross Margin N/A
Operating Margin -40.5%
Net Margin 58.9%
ROE N/A
ROA 5.6%
FCF Margin -28.8%

Balance Sheet & Liquidity

Current Ratio
0.03x
Quick Ratio
0.03x
Debt/Equity
N/A
Debt/Assets
16.3%
Interest Coverage
-59.24x
Long-term Debt
4.5K
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-03-21T03:58:14.447297 | Data as of: 2025-11-30 | Powered by Claude AI